Citations 270
TP53 Mutation Status Defines a Distinct Clinicopathological Entity of Therapy-Related Myeloid Neoplasm, Characterized By Genomic Instability and Extremely Poor Outcome
Sharplin, Kirsty, Chhetri, Rakchha , Ladon, Dariusz, Al‐Kali, Aref , Litzow, Mark R. , Mangaonkar, Abhishek A. , Gangat, Naseema , Patnaik, Mrinal M. , Begna, Kebede, Tefferi, Ayalew , Shah, Meera , Hahn, Christopher N , Tran, Elizabeth Ngoc Hoa , Baranwal, Anmol , Kutyna, Monika , Wang, Paul Po-Shen , Alkhateeb, Hassan B. , Ross, David M , Yeung, David , Shanmuganathan, Naranie , Hogan, William J. , Kumar, Sharad , Singhal, Deepak , Brown, Anna , Scott, Hamish S. , THOMAS, DANIEL W. , Kok, Chung Hoow , Hiwase, Devendra
Blood | November 28, 2022 | Volume: 140 | Issue: Supplement 1 | Pages: 9798-9799
Characteristics and Outcomes of Radiation Therapy-Related Myeloid Neoplasms
Shultz, Carl , Al‐Kali, Aref , Chhetri, Rakchha , Arsana, Arini, Stish, Bradley J. , Tefferi, Ayalew , Patnaik, Mrinal M. , Gangat, Naseema , Baranwal, Anmol , Tran, Elizabeth Ngoc Hoa , Alkhateeb, Hassan B. , Hiwase, Devendra , Shah, Meera
Blood | November 28, 2022 | Volume: 140 | Issue: Supplement 1 | Pages: 6309-6311
Venetoclax Plus Hypomethylating Agent (HMA) Based Induction for Treatment-Naive Older/Unfit Patients with FLT3-Mutated Acute Myeloid Leukemia (AML)
Ghorab, Ahmad , Litzow, Mark R. , Gangat, Naseema , Al‐Kali, Aref , Tefferi, Ayalew , Begna, Kebede H. , Patnaik, Mrinal M. , Foran, James M. , Ghorab, Ahmad , Shah, Meera , Murthy, Hemant S. , Alkhateeb, Hassan B. , Badar, Talha
Blood | November 28, 2022 | Volume: 140 | Issue: Supplement 1 | Pages: 9019-9020
CAR-T Prescriber Preferences in Adolescents and Young Adults with B-ALL
Aquino, Victor , Hudspeth, Michelle, Rangarajan, Hemalatha G. , Anderson, Eric , Kelly, Susan, Ramachandran, Shanti , Lin, Yi , Kohorst, Mira A. , Godby, Richard , Ferdjallah, Asmaa , Alkhateeb, Hassan B. , Kitko, Carrie L. , Modi, Arunkumar J. , Katsanis, Emmanuel
Blood | November 28, 2022 | Volume: 140 | Issue: Supplement 1 | Pages: 12762-12763
Outcome of Patients with Acute Myeloid Leukemia Following Failure of Front-Line Venetoclax Plus Hypomethylating Agent Therapy
Ilyas, Rimal, Johnson, Isla McKerrow , Al‐Kali, Aref , Begna, Kebede, Mangaonkar, Abhishek A. , Litzow, Mark R. , Patnaik, Mrinal M. , Pardanani, Animesh , Tefferi, Ayalew, Gangat, Naseema , McCullough, Kristen , Alkhateeb, Hassan B. , Hogan, William J. , Shah, Meera , Tefferi, Ayalew
Blood | November 28, 2022 | Volume: 140 | Issue: Supplement 1 | Pages: 1286-1287
Performance of Glomerular Filtration Rate Estimating Equations in Cancer Patients Evaluated for Chimeric Antigen Receptor T-Cell Therapy
Barreto, Jason N. , Frazee, Erin N. , Powell, Marissa , Bansal, Radhika , Hathcock, Matthew , Nedved, Adrienne, Ansell, Stephen M. , Johnston, Patrick B. , Sandahl, Tyler B. , Khurana, Arushi , Kapoor, Prashant , Kumar, Shaji , Kourelis, Taxiarchis , Warsame, Rahma , Hayman, Suzanne R. , Lin, Yi , Mara, Kristin C. , Rule, Andrew D. , Herrmann, Sandra M. , Bennani, N. Nora , Paludo, Jonas , Durani, Urshila , Wang, Yucai , Alkhateeb, Hassan B. , Shah, Meera , Gertz, Morie A. , Dingli, David , Leung, Nelson
Blood | November 28, 2022 | Volume: 140 | Issue: Supplement 1 | Pages: 10942-10944
Response Rates to Venetoclax Based Therapies in Chronic Phase and Blast Transformed Chronic Myelomonocytic Leukemia
Litzow, Mark R. , Gangat, Naseema , Al‐Kali, Aref , Foran, James M. , Palmer, Jeanne , Mangaonkar, Abhishek A. , McCullough, Kirsten, Tefferi, Ayalew , Patnaik, Mrinal M. , Csizmar, Clifford M. , Saliba, Antoine N. , Hogan, William J. , McCullough, Kirsten, Alkhateeb, Hassan B.
Blood | November 28, 2022 | Volume: 140 | Issue: Supplement 1 | Pages: 12238-12240
Leukemic Transformation of Myeloproliferative Neoplasms in the Post-Ruxolitinib Era: Analysis of 103 Consecutive Cases Diagnosed 2011-2021
Abdelmagid, Maymona, Al‐Kali, Aref , Begna, Kebede H. , Litzow, Mark R. , Mangaonkar, Abhishek A. , Patnaik, Mrinal M. , Elliott, Michelle A. , Howard, Matthew O. , Reichard, Kaaren K. , Pardanani, Animesh , Gangat, Naseema , Tefferi, Ayalew , Hogan, William J. , Alkhateeb, Hassan B. , Shi, Min , Howard, Matthew, Ketterling, Rhett P.
Blood | November 28, 2022 | Volume: 140 | Issue: Supplement 1 | Pages: 9735-9736
Personalized Prediction Model to Risk Stratify Patients with Therapy-Related Myeloid Neoplasms
Ladon, Dariusz, Chhetri, Rakchha , Sharplin, Kirsty, Al‐Kali, Aref , Gangat, Naseema , Litzow, Mark R. , Kebede, Ashanka Begna, Mangaonkar, Abhishek A. , Patnaik, Mrinal M. , Tefferi, Ayalew , Kok, Chung Hoow , Tran, Elizabeth Ngoc Hoa , Baranwal, Anmol , Alkhateeb, Hassan B. , Singhal, Deepak , Yeung, David , Ross, David M , Hogan, William J. , Shanmuganathan, Naranie , Kumar, Sharad , THOMAS, DANIEL W. , Shah, Meera , Hiwase, Devendra
Blood | November 28, 2022 | Volume: 140 | Issue: Supplement 1 | Pages: 6962-6963
Integrated Personalized Prediction Model Identifies a Subgroup of Wild-Type TP53therapy-Related Myeloid Neoplasm Patients with Poor Outcome
Chhetri, Rakchha , Al‐Kali, Aref , Gangat, Naseema , Litzow, Mark R. , Begna, Kebede, Mangaonkar, Abhishek A. , Patnaik, Mrinal M. , Tefferi, Ayalew , Shah, Meera , Hahn, Christopher N , Tran, Elizabeth Ngoc Hoa , Singhal, Deepak , Hogan, William J. , Kutyna, Monika , Alkhateeb, Hassan B. , Baranwal, Anmol , Shanmuganathan, Naranie , Kumar, Sharad , THOMAS, DANIEL W. , Kok, Chung Hoow , Hiwase, Devendra
Blood | November 28, 2022 | Volume: 140 | Issue: Supplement 1 | Pages: 6964-6965